Elham Masoumi

951 total citations
26 papers, 701 citations indexed

About

Elham Masoumi is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Elham Masoumi has authored 26 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 11 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Elham Masoumi's work include CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (6 papers) and COVID-19 Clinical Research Studies (4 papers). Elham Masoumi is often cited by papers focused on CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (6 papers) and COVID-19 Clinical Research Studies (4 papers). Elham Masoumi collaborates with scholars based in Iran, United States and Germany. Elham Masoumi's co-authors include Leila Jafarzadeh, Jamshid Hadjati, Keyvan Fallah-Mehrjardi, Hamid Reza Mirzaei, Seyed Amir Jalali, Jalil Tavakkol‐Afshari, Mahmoud Reza Jaafari, Seyed‐Alireza Esmaeili, Farshid Noorbakhsh and Leila Mobasheri and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Elham Masoumi

25 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elham Masoumi Iran 13 291 289 239 97 97 26 701
Brandon Lam United States 13 149 0.5× 270 0.9× 325 1.4× 57 0.6× 60 0.6× 34 766
Nathan D. Pennock United States 18 281 1.0× 248 0.9× 539 2.3× 72 0.7× 113 1.2× 33 977
Jingying Zhou China 16 281 1.0× 303 1.0× 308 1.3× 220 2.3× 41 0.4× 51 1.0k
Zachary Roberts United States 16 362 1.2× 279 1.0× 412 1.7× 154 1.6× 104 1.1× 34 1.1k
Arnab Ghosh United States 15 295 1.0× 383 1.3× 451 1.9× 108 1.1× 79 0.8× 51 1.2k
James Thaventhiran United Kingdom 13 156 0.5× 255 0.9× 488 2.0× 146 1.5× 93 1.0× 27 863
Ida H. Hiemstra Netherlands 16 324 1.1× 193 0.7× 390 1.6× 54 0.6× 57 0.6× 29 846
Valeria Milani Germany 12 149 0.5× 419 1.4× 286 1.2× 53 0.5× 35 0.4× 28 762
Almohanad A. Alkayyal Saudi Arabia 12 374 1.3× 273 0.9× 321 1.3× 79 0.8× 188 1.9× 29 903

Countries citing papers authored by Elham Masoumi

Since Specialization
Citations

This map shows the geographic impact of Elham Masoumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elham Masoumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elham Masoumi more than expected).

Fields of papers citing papers by Elham Masoumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elham Masoumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elham Masoumi. The network helps show where Elham Masoumi may publish in the future.

Co-authorship network of co-authors of Elham Masoumi

This figure shows the co-authorship network connecting the top 25 collaborators of Elham Masoumi. A scholar is included among the top collaborators of Elham Masoumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elham Masoumi. Elham Masoumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arina, Ainhoa, Edwin Araúz, Elham Masoumi, et al.. (2025). A universal chimeric antigen receptor (CAR)–fragment antibody binder (FAB) split system for cancer immunotherapy. Science Advances. 11(27). eadv4937–eadv4937.
2.
Masoumi, Elham, Leila Jafarzadeh, Keyvan Fallah-Mehrjardi, et al.. (2023). MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor Cells. Iranian Journal of Allergy Asthma and Immunology. 22(1). 62–71. 2 indexed citations
3.
Masoumi, Elham, et al.. (2022). Interleukin‐29 profiles in COVID‐19 patients: Survival is associated with IL‐29 levels. Health Science Reports. 5(2). e544–e544. 12 indexed citations
4.
Jafarzadeh, Leila, Elham Masoumi, Keyvan Fallah-Mehrjardi, et al.. (2022). Restricting tumor lactic acid metabolism using dichloroacetate improves T cell functions. BMC Cancer. 22(1). 39–39. 44 indexed citations
5.
Mobasheri, Leila, et al.. (2022). SARS-CoV-2 triggering autoimmune diseases. Cytokine. 154. 155873–155873. 76 indexed citations
6.
Jafarzadeh, Leila, Elham Masoumi, Hamid Reza Mirzaei, et al.. (2021). Targeted knockdown of Tim3 by short hairpin RNAs improves the function of anti-mesothelin CAR T cells. Molecular Immunology. 139. 1–9. 25 indexed citations
7.
Birtel, Matthias, Elham Masoumi, Leila Jafarzadeh, et al.. (2021). CRISPR/Cas9-mediated TGFβRII disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells in vitro. Journal of Translational Medicine. 19(1). 482–482. 27 indexed citations
8.
Masoumi, Elham, et al.. (2021). The application of immune checkpoint blockade in breast cancer and the emerging role of nanoparticle. Journal of Controlled Release. 340. 168–187. 29 indexed citations
9.
Masoumi, Elham, et al.. (2021). Serum Levels of Soluble Fas and Fas Ligand in Iranian Women with Pre-eclampsia. PubMed. 9(4). 394–398. 1 indexed citations
10.
Masoumi, Elham, et al.. (2021). The role of Th22 cells, from tissue repair to cancer progression. Cytokine. 149. 155749–155749. 22 indexed citations
11.
12.
Mirzaei, Asad, Maryam Maleki, Elham Masoumi, & Nahid Maspi. (2020). A historical review of the role of cytokines involved in leishmaniasis. Cytokine. 145. 155297–155297. 26 indexed citations
13.
Jafarzadeh, Leila, Elham Masoumi, Hamid Reza Mirzaei, et al.. (2020). Construction and Functional Characterization of a Fully Human Anti-mesothelin Chimeric Antigen Receptor (CAR)-expressing T Cell. Iranian Journal of Allergy Asthma and Immunology. 19(3). 264–275. 6 indexed citations
14.
Fallah-Mehrjardi, Keyvan, Hamid Reza Mirzaei, Elham Masoumi, et al.. (2020). Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitro. Immunology Letters. 223. 44–52. 11 indexed citations
15.
Mirzaei, Hamid Reza, Leila Jafarzadeh, Elham Masoumi, et al.. (2018). Construction and functional characterization of a fully human anti‐CD19 chimeric antigen receptor (huCAR)‐expressing primary human T cells. Journal of Cellular Physiology. 234(6). 9207–9215. 34 indexed citations
16.
Tavakkol‐Afshari, Jalil, et al.. (2017). Improved Immunogenicity Against a Her2/neu-Derived Peptide by Employment of a Pan HLA DR-Binding Epitope and CpG in a BALB/c Mice Model. Anti-Cancer Agents in Medicinal Chemistry. 17(6). 851–858. 7 indexed citations
17.
Masoumi, Elham, et al.. (2017). Methylprednisolone versus Dexamethasone for Control of Vertigo in Patients with Definite Meniere's disease.. PubMed. 29(95). 341–346. 10 indexed citations
18.
Masoumi, Elham, et al.. (2016). Relationship between Fas and Fas Ligand gene polymorphisms and pre‐eclampsia. Journal of obstetrics and gynaecology research. 42(10). 1272–1278. 7 indexed citations
19.
Tavakkol‐Afshari, Jalil, et al.. (2015). Improving Multi-Epitope Long Peptide Vaccine Potency by Using a Strategy that Enhances CD4+ T Help in BALB/c Mice. PLoS ONE. 10(11). e0142563–e0142563. 131 indexed citations
20.
Vakili, Rahim, Mohsen Nematy, Abdolreza Norouzy, et al.. (2013). The Effect of Ramadan Fasting on Thyroid Hormones in 9‐13 Years Old Pre‐Menarche Girls. SHILAP Revista de lepidopterología. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Brandon Lam Breakdown of academic impact, for papers by Nathan D. Pennock Breakdown of academic impact, for papers by Jingying Zhou Breakdown of academic impact, for papers by Zachary Roberts Breakdown of academic impact, for papers by Arnab Ghosh Breakdown of academic impact, for papers by James Thaventhiran Breakdown of academic impact, for papers by Ida H. Hiemstra Breakdown of academic impact, for papers by Valeria Milani Breakdown of academic impact, for papers by Almohanad A. Alkayyal
Rankless by CCL
2026